期刊文献+

脂蛋白脂酶基因多态性与冠心病关系的初探 被引量:11

Initial study on the association of lipoprotein lipase (LPL) gene polymorphisms with coronary heart disease (CHD)
原文传递
导出
摘要 目的探讨脂蛋白脂酶(LPL)基因多态性与冠心病的关系。方法选择106例住院存活的心肌梗塞病人按1∶1进行病例对照研究,采用条件Logistic回归分析。结果吸烟、LPL基因型PVUⅡ(--)和单倍体基因型H+P-是冠心病独立的危险因素;高密度脂蛋白胆固醇(HDL-C)和载脂蛋白(Apo)A/B比值是冠心病的保护因素。去除其它因素的影响后,LPLPVUⅡ(--)/非(--)和H+P-/非H+P-的OR值为17.18和3.67;HDL-C、ApoA/B比值的OR值在模型A和B中分别为0.14、0.15和0.04、0.09。结论除传统的危险因素外,LPL基因型PVUⅡ(--)和单倍体H+P-可能是易患冠心病的遗传标志;HDL-C。 Objective To explore the association of LPL gene polymorphisms with CHD. Methods 106 patients in myocardial infarction survivors were analyzed through a casecontrol study. Results The conditional logistic regression analysis demonstrated that 5 factors were associated with CHD. The risk factors were smoking, LPL genotype PVUⅡ(--) and haplotype H+P-, while high density lipoprotein cholesterol (HDLC), apolipoprotein A/B (ApoA/B) ratio seemed as protective factors. After controlling the effect of the other variables, OR of LPL genotype PVUⅡ(--) and haplotype H+P- were 17.18 and 3.67, while OR of HDLC, ApoA/B ratio were respectively 0.14, 0.15 in model A and 0.04, 0.09 in model B. Conclusion These results indicated that LPL genotype PVUII(--) or haplotype H+P- other than the conventional risk factors were contributing in CHD and that HDLC, ApoA/B ratio may be the better independent predictors for CHD than the other plasma lipid parameters.
出处 《中华心血管病杂志》 CAS CSCD 北大核心 1998年第4期309-312,共4页 Chinese Journal of Cardiology
关键词 冠心病 脂蛋白脂酶 基因多态性 lipoprotein lipase gene, POL coronary heart disease
  • 相关文献

参考文献4

  • 1Wang X L,Circulation,1996年,93卷,1339页
  • 2王克勤,脂蛋白与动脉粥样硬化,1995年,222页
  • 3吴锡桂,中国循环杂志,1991年,6卷,127页
  • 4周北凡,心血管病流行病学及人群防治,1991年,86页

同被引文献75

引证文献11

二级引证文献62

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部